Iván Cornella-Taracido, Ph.D.
Vice President, Proteomics and Chemical Biology
Iván Cornella-Taracido joins Cedilla from Merck Research Laboratories, where he was the director of chemical biology. Prior to Merck, Iván held leadership positions at AstraZenca, where he established and managed the global chemical biology team; Sanofi, where he founded the chemical genetics and proteomics team; and Novartis, where he was a founding member of the small molecule target identification and mode of action elucidation (TIDMoA) platform. Iván has a B.Sc. in chemistry, an M.Sc. in organic chemistry and a Ph.D. in organic chemistry from the Universidade da Coruña in Spain. He completed postdoctoral work at the Institute of Chemistry & Cell Biology of Harvard Medical School (now the Broad Institute of MIT and Harvard) and in the Boston College chemistry department.